Holen Sie sich die Stockscreener-App
3.61
2.56%
0.09
Handel nachbörslich:
3.61
Schlusskurs vom Vortag:
$3.52
Offen:
$3.52
24-Stunden-Volumen:
1.78M
Relative Volume:
0.61
Marktkapitalisierung:
$408.14M
Einnahmen:
$1.89B
Nettoeinkommen (Verlust:
$-496.52M
KGV:
-0.7584
EPS:
-4.7598
Netto-Cashflow:
$1.40M
1W Leistung:
-2.17%
1M Leistung:
-26.18%
6M Leistung:
+59.03%
1J Leistung:
-59.53%
1-Tages-Spanne:
$3.435
$3.655
1-Wochen-Bereich:
$3.435
$3.81
52-Wochen-Spanne:
$2.095
$9.105
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, TXG, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.61 | 408.14M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
280.68 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
85.01 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
56.59 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
85.71 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
HNGE
Hinge Health Inc
|
95.57 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
US30050BAG6 Bond Profile: Coupon and Redemption - TradingView
EVH6495551 Bond Profile: Coupon and Redemption - TradingView
Evolent Health (EVH) Short Interest & Short Float | Updated Sep 2026 $EVH - MarketBeat
Evolent Health, Inc. (EVH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Evolent Health stock gains on a TransPerfect expansion - AD HOC NEWS
3 Reasons to Avoid EVH and 1 Stock to Buy Instead - Yahoo Finance
Evolent Health expands language services deal with TransPerfect By Investing.com - Investing.com Nigeria
Evolent Health expands language services deal with TransPerfect - Investing.com
TransPerfect Wins Evolent Telephonic Interpretation Deal - TradingView
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses - Yahoo Finance
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Evolent program flags low-value regimen years ahead of failed clinical trial - RamaOnHealthcare
Morgan Stanley slips under 5% in Evolent Health (NYSE: EVH) - Stock Titan
EVH6495551 Latest News and Headlines - TradingView
Evolent Health (EVH) President Daniel Mccarthy Sells 65,892 Shar - GuruFocus
Evolent Health President Daniel Joseph McCarthy sells 65,892 shares for $329,460 - Bitget
EVH6495551 Bond Yield and Price — FINRA:EVH6495551 - TradingView
Evolent Health (EVH) Institutional Ownership 2026 $EVH - MarketBeat
Evolent Health (NYSE: EVH) officer lines up 2026 stock sale - Stock Titan
EVH | Evolent Health, Inc Class FinancialsRevenue Breakdown - quiverquant.com
EVH Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus
EVH Maintained by TD Cowen -- Price Target Raised to $6.00 - GuruFocus
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $6 - Moomoo
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo
1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance
EVH Q2 2026 Earnings: EPS Swing to Positive Territory Delivers 183.68% SurpriseEarnings Surprise Stocks - careplusvn.com
Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com
Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang
Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha
Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail
Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com
EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus
Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo
Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia
Truist cuts Evolent Health stock price target on execution risks - Investing.com
Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com
Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com
EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Evolent Health, Inc. (EVH) Stock Analysis: A Healthcare Tech Player with a 46% Potential Upside - DirectorsTalk Interviews
Evolent Health Price Target Cut to $6.00/Share From $7.00 by Canaccord Genuity - Moomoo
Citi Upgrades Evolent Health(EVH.US) to Buy Rating, Cuts Target Price to $6 - Moomoo
Evolent Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:EVH) 2026-08-10 - Seeking Alpha
EVH Looks 60.0% Undervalued on GF Value™ Despite Profitability C - GuruFocus
Canaccord cuts Evolent Health stock price target on margin outlook By Investing.com - Investing.com Nigeria
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):